Journal of Drug Discovery and Research

Liu Duo, Professor, Chief Pharmacist; Doctoral Supervisor. PhD, Postdoctoral Fellow in Basic Medicine. Distinguished Young Scholar of Heilongjiang Province, Star-linked Faculty of Harbin Medical University, Outstanding Young Talent and Top Young Talent of the Affiliated Cancer Hospital of Harbin Medical University, Visiting Scholar in the United States. He has presided over more than ten projects including the National Natural Science Foundation, Heilongjiang Provincial Natural Science Foundation, China Postdoctoral Fund, Heilongjiang Postdoctoral Fund, and preferential support programs for returning overseas scholars. He has published 15 SCI papers as the first or corresponding author, with the highest impact factor of a single paper being 12.701. He has won the Second Prize of New Technology in Heilongjiang Province and the First Prize of New Medical Technology at Harbin Medical University, one each. He serves in multiple national academic positions and editorial boards of journals.

Associate Professor Dr Chan Siok Yee is a fully registered pharmacist and a member of academic staff and program chair of discipline pharmaceutical technology in the School of Pharmaceutical Science, Universiti Sains Malaysia. Being a young academic, Siok Yee has proved her ability in outperform her peers in research. She holds a number of research grants including an international grant, industrial as well as government grant for research. Dr Chan Siok Yee is visionary, she established her own research group which is named of Thought Formulation Lab. On top of that, Siok Yee has a great leadership quality which could be seen from her affiliation to several societies such as co-lead of focus area in Global Young Academy, Education specialist of Melaka Action Group for Parent in Education, member of the Malaysian Pharmacy Society, Editor in Chief for Malaysian Journal of Pharmacy, Chair of Science Leadership Working group in the Young Scientist Network and serves as the President for Malaysia Society of Pharmaceutical Technology.

Dr. Narsimha Mamidi is a Staff Scientist at the School of Pharmacy, University of Wisconsin-Madison, with extensive expertise in nanomedicine, drug delivery, biomaterials, and translational cancer research. He earned his Ph.D. in Chemical Sciences from IIT Guwahati, India, where he received the Eli Lilly Outstanding Thesis Award. His interdisciplinary research focuses on the development of peptide-conjugated lipid nanoparticles, engineered hydrogels, and nanocomposites for targeted drug and gene delivery, with applications in cancer immunotherapy, pulmonary diseases, and regenerative medicine. Dr. Mamidi has held academic positions in India, Mexico, and the USA, and has mentored numerous students across doctoral, master's, and undergraduate levels. He has authored over 45 peer-reviewed publications in high-impact journals such as Nature Biotechnology, Advanced Healthcare Materials, Nanoscale, and Nano Today, and has been recognized with several awards, including the 2022 Outstanding Reviewer Award from Polymers. His technical skill set spans synthetic organic chemistry, peptide synthesis, nanoparticle engineering, CRISPR-based EV analysis, and a range of analytical and imaging techniques. Passionate about bridging lab-scale innovations with clinical applications, he actively contributes to research, teaching, and academic outreach across global platforms.

I am Dr. Ziyaul Haque Shakeel Ahmad, an Assistant Professor in the Department of Pharmaceutical Chemistry at the School of Pharmacy, Anjuman-I-Islam Kalsekar Technical Campus. With over 10 years of teaching and research experience, I specialize in drug design, QSAR modeling, molecular docking, spectroscopy, and medicinal chemistry.
I hold an M. Pharmacy in Pharmaceutical Chemistry (Distinction, 2014) and a B. Pharmacy (2012), and I am currently pursuing my Ph.D. at Maulana Azad University, Jodhpur, focusing on anti-urolithiasis drug design using computational approaches.
My research has resulted in multiple publications in reputed international journals such as International Immunopharmacology, Journal of Alzheimer’s Disease, Arabian Journal of Chemistry, and European Journal of Pharmacology. I have delivered guest lectures, organized conferences, and received awards at national and international forums for my research presentations.
I am also a life member of APTI and SPER, and I actively contribute to student learning through my YouTube channel “Alchemia.EasyChem” and my educational website.
With a passion for teaching, research, and innovation, I aim to contribute significantly to the advancement of pharmaceutical sciences and inspire future professionals in this field.

Dr. Shazia Usmani is an accomplished academic and researcher with expertise in pharmaceutical sciences. She has extensive teaching and research experience, focusing on drug design, medicinal chemistry, and pharmacology. Dr. Usmani has contributed to numerous publications in peer-reviewed journals and actively participates in academic collaborations and scientific events. She is dedicated to advancing research and education in her field and brings strong leadership and editorial skills to her professional roles.

Dr. Fawzy A. Saad is currently the Chief Executive Officer of Saad Pharmaceuticals in Tallinn, Estonia, where he leads innovative biopharmaceutical research focused on gene therapy and precision medicine for rare genetic and age-related disorders. He is a renowned molecular geneticist and biotechnology expert with over 30 years of international experience in genetic research, gene therapy, and orthopaedic molecular biology. He holds a Ph.D. in Human Molecular Genetics from Padua University, Italy, and has conducted pioneering research across esteemed institutions including the University of Toronto, Wake Forest University, Harvard Medical School, and Albert Einstein College of Medicine. His extensive work spans dystrophinopathies, bone remodeling, tendon regeneration, and metabolic bone diseases, resulting in over 45 peer-reviewed publications and multiple patents. Dr. Saad has also served as a scientific advisor and editorial board member for leading journals, mentored numerous researchers, and led training in advanced molecular techniques.

Dr. Yasameen Hmeed Jasim Al-Daraji is a Lecturer in Biochemistry at the University of Samarra, Iraq, with over a decade of academic and research experience. She holds an M.Sc. in Biochemistry and is currently pursuing her Ph.D. in Clinical Chemistry at Erciyes University, Turkey, focusing on molecular markers in brain cancer. Her research spans clinical biochemistry, metabolic disorders, and the therapeutic effects of natural compounds. She has published several peer-reviewed studies on topics such as the impact of plant-derived flavonoids on diabetic and liver disease models, UVC radiation effects, and microbial nutrient media production. Her work appears in journals like the International Journal of Science & Technology, Tikrit Journal of Pure Sciences, and Karbala Journal of Pharmaceutical Sciences. Dr. Al-Daraji has also contributed to curriculum development, scientific committees, and quality assurance initiatives within her institution. She is fluent in English and Turkish, with international certifications and active participation in scientific conferences.